Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro
- 20 January 1994
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (2) , 171-174
- https://doi.org/10.1016/0006-2952(94)90002-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growthJournal of Medicinal Chemistry, 1992
- Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compoundsThe Journal of Organic Chemistry, 1992
- Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.Published by Elsevier ,1992
- Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV)The Journal of Organic Chemistry, 1992
- Preparation of the geometric isomers of DDC, DDA, D4C and D4T as potential anti-HIV agentsBioorganic & Medicinal Chemistry Letters, 1991
- Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analogAntimicrobial Agents and Chemotherapy, 1991
- Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesisAntimicrobial Agents and Chemotherapy, 1991
- An in vitro system for screening anti-hepatitis b virus drugsVirology, 1989
- Hepatocellular CarcinomaAnnals of Internal Medicine, 1988
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981